Skip to content
Thursday, June 4
  • Finance
  • Health
  • Sports
  • World
  • Press Release
The Prime India

The Prime India

The Prime India

The Prime India

  • Business
  • Entertainment
  • Lifestyle
  • National
  • Technology
  • Education
  • Business
  • Entertainment
  • Lifestyle
  • National
  • Technology
  • Education
Trending Now
  • Remittix Smashes Through $30M, The Clock Is Now Ticking On An RTX Launch Date Reveal
  • India’s Blood Sugar Problem Is No Longer Only About Diabetes
  • Introducing Quantitative Research Using R Co-authored by Prof. Kiran Pandya and Dr. Smruti Bulsari (Published by Routledge)
  • Sathlokhar Synergys E&C Global Limited Registers Stellar FY26 Performance as Total Income Rises 121% YoY to Rs 824 Cr and PAT Surges 141% YoY to Rs 82 Cr
  • Designed for royalty: The Crown Collection by Mayfair Housing elevates township living in Virar with a luxurious touch
  • Srinibas Pradhan Constructions Limited Reports Strong H2 & FY26 Performance; H2 EBITDA and PAT Margins Expand by 481 Bps and 346 Bps
Home>>Business>>Chandan Healthcare Enters Maharashtra and West Bengal; Launches Mumbai, Kolkata & Kota Diagnostic Centres
Business

Chandan Healthcare Enters Maharashtra and West Bengal; Launches Mumbai, Kolkata & Kota Diagnostic Centres

Ansh Singh
March 19, 2026

lucknow (Uttar Pradesh) [India], March 19:: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading diagnostic and healthcare service providers in North India, has expanded its presence with the launch of new diagnostic centres in Mumbai and Kolkata, marking its entry into Maharashtra and West Bengal. The Company has also commenced diagnostic operations in Kota (Rajasthan), further strengthening its growing network across India.

The Mumbai and Kolkata centres are equipped to offer comprehensive diagnostic services, including pathology and blood investigations, along with advanced tests such as TMT, ECG, EEG, and PFT. These centres are designed to cater to a wide range of patient requirements while also supporting diagnostic needs of associated partner centres across the network, enabling integrated and efficient service delivery.

The Company plans to further enhance capabilities at these facilities by introducing additional diagnostic services such as X-Ray and Bone Mineral Density (BMD) in due course, strengthening its service portfolio and improving overall diagnostic accessibility.

In addition, Chandan Healthcare has commenced diagnostic operations in Kota (Rajasthan) as part of its ongoing rollout under the previously announced five-year strategic partnership with Jeena Sikho Lifecare Limited. As the exclusive diagnostic partner for Jeena Sikho hospitals and clinics, the Company will continue to expand diagnostic services across additional facilities under this collaboration.

This expansion is expected to strengthen the Company’s overall diagnostic network, improve access to quality healthcare services, and support higher patient volumes. The launch of centres in Mumbai and Kolkata enhances its presence in key urban markets, while the Kota operations support execution of its partnership-led expansion strategy and long-term growth plans.

Commenting on the development, Mr. Amar Singh, Promoter and Managing Director of Chandan Healthcare Limited, said, “We are pleased to expand our presence into Maharashtra and West Bengal, along with the rollout of operations under the Jeena Sikho partnership in Kota. This aligns with our strategy to build a scalable and integrated diagnostic network

We remain focused on enhancing accessibility, strengthening our service capabilities, and expanding our presence across high-growth regions. At the same time, we will continue to invest in expanding our diagnostic offerings and supporting our partner network to deliver consistent and high-quality healthcare services.”

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Related tags : Business

Previous Post

HEC Infra Projects Limited Secures Rs 36.50 Cr EPC Order for 10.4 MW Solar Power Plant

Next Post

Cupid Limited Announces Development of Nitrile Female Condom Targeting Global Monopoly Segment and Strategic Branding Alignment: “Made in India” with “Japanese Quality”

Related Articles

Business

Offmint’s Journey & Rani Ahluwalia’s Support: A Game-Changing Shark Tank India Pitch

Business

Swift Money announces the appointment of ex-COO of ANZ Bank to its advisory board

Business

#FevikwikStars celebrates people who have a natural talent of breaking things.

Business

Sports technology, renewable energy, and more: Queensland’s Minister seeks opportunities in India

Business

Celebrating 25 Years: CritiCare Asia & IIFA Foundation Offer Free Check-Ups to 500 Workers

Recent Posts

  • Remittix Smashes Through $30M, The Clock Is Now Ticking On An RTX Launch Date Reveal
  • India’s Blood Sugar Problem Is No Longer Only About Diabetes
  • Introducing Quantitative Research Using R Co-authored by Prof. Kiran Pandya and Dr. Smruti Bulsari (Published by Routledge)
  • Sathlokhar Synergys E&C Global Limited Registers Stellar FY26 Performance as Total Income Rises 121% YoY to Rs 824 Cr and PAT Surges 141% YoY to Rs 82 Cr
  • Designed for royalty: The Crown Collection by Mayfair Housing elevates township living in Virar with a luxurious touch

Search

For more Details

editor@bestnewsjournal.com

Recent Posts

  • Remittix Smashes Through $30M, The Clock Is Now Ticking On An RTX Launch Date Reveal
  • India’s Blood Sugar Problem Is No Longer Only About Diabetes
  • Introducing Quantitative Research Using R Co-authored by Prof. Kiran Pandya and Dr. Smruti Bulsari (Published by Routledge)
  • Sathlokhar Synergys E&C Global Limited Registers Stellar FY26 Performance as Total Income Rises 121% YoY to Rs 824 Cr and PAT Surges 141% YoY to Rs 82 Cr
  • Designed for royalty: The Crown Collection by Mayfair Housing elevates township living in Virar with a luxurious touch
  • Srinibas Pradhan Constructions Limited Reports Strong H2 & FY26 Performance; H2 EBITDA and PAT Margins Expand by 481 Bps and 346 Bps
© 2026 The Prime India | WordPress Theme Ultra News
  • Contact
  • Sample Page
  • Sample Page